TRPA1 and hyperlipidemia: Administration of the TRPA1 channel antagonist HC030031 or knockout of the TRPA1 [TRPA1 (-/-)] gene in apoE (-/-) mice can exacerbate atherosclerotic lesions, hyperlipidemia, and systemic inflammation (Zhao et al., 2016).